Novel Drug Improves Sleep and Maternal Care in Rat Mothers

The hypocretin system (also known as orexin system) plays a critical role in regulating wakefulness, appetite, and reward. Disruptions in this system can lead to sleep disorders. Lactation is a period often associated with significant sleep fragmentation and altered maternal behaviors, which can negatively impact both the mother and offspring's well-being. This study aimed to investigate whether modulating the hypocretin system could improve sleep quality and enhance nursing behavior in lactating rats.

The study found that OrexinBlock significantly improved sleep parameters and maternal care. At the 1.0 mg/kg dose, rats exhibited a 35% increase in Non-REM (NREM) sleep duration (p<0.001) and a 20% increase in REM sleep duration (p<0.01) compared to the saline control group. Sleep fragmentation, characterized by the number of awakenings, was reduced by 40% (p<0.005). This indicates a more consolidated and restorative sleep pattern. > Most notably, the treated group at 1.0 mg/kg showed a remarkable 50% increase in active nursing time and a 2.3-fold improvement in pup retrieval latency, demonstrating significantly enhanced maternal care behaviors compared to controls (p<0.001). These improvements were dose-dependent, with the higher dose yielding more pronounced effects.